C07K 14/585
Calcitonins
C07K14/585 (Calcitonins) appears on 226 US grants and 131 published applications in this corpus.
Search patents in C07K- Granted patents
- 226
- Published applications
- 131
- Assignees
- 125
- Inventors
- 398
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 3 | 0 |
| 1978 | 2 | 0 |
| 1979 | 2 | 0 |
| 1980 | 3 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 6 | 0 |
| 1984 | 5 | 0 |
| 1985 | 6 | 0 |
| 1986 | 13 | 0 |
| 1987 | 13 | 0 |
| 1988 | 6 | 0 |
| 1989 | 4 | 0 |
| 1990 | 0 | 0 |
| 1991 | 6 | 0 |
| 1992 | 5 | 0 |
| 1993 | 5 | 0 |
| 1994 | 6 | 0 |
| 1995 | 5 | 0 |
| 1996 | 7 | 0 |
| 1997 | 5 | 0 |
| 1998 | 5 | 0 |
| 1999 | 7 | 0 |
| 2000 | 11 | 0 |
| 2001 | 5 | 3 |
| 2002 | 5 | 7 |
| 2003 | 4 | 8 |
| 2004 | 6 | 8 |
| 2005 | 2 | 5 |
| 2006 | 5 | 7 |
| 2007 | 2 | 3 |
| 2008 | 3 | 7 |
| 2009 | 3 | 7 |
| 2010 | 5 | 8 |
| 2011 | 9 | 4 |
| 2012 | 3 | 6 |
| 2013 | 5 | 3 |
| 2014 | 4 | 9 |
| 2015 | 5 | 7 |
| 2016 | 6 | 5 |
| 2017 | 4 | 5 |
| 2018 | 2 | 6 |
| 2019 | 6 | 3 |
| 2020 | 3 | 4 |
| 2021 | 1 | 1 |
| 2022 | 1 | 6 |
| 2023 | 0 | 4 |
| 2024 | 1 | 1 |
| 2025 | 2 | 2 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Peptide immunogens targeting calcitonin gene-related peptide (CGRP) and formulations thereof for prevention and treatment of migraine16 Jun 2026US 12,655,187 B2United Neuroscience
- Degradable multi-arm polyethylene glycol derivative2 Sep 2025US 12,404,367 B2Nof Corporation
- Branched degradable polyethylene glycol binder19 Aug 2025US 12,390,534 B2Nof Corporation
- Peptide analogs8 Oct 2024US 12,110,318 B2Adepthera LLC
- Peptide analogs19 Jul 2022US 11,390,657 B2Adepthera LLC
- Stabilized analogues of calcitonin8 Oct 2026US 2026/0308222 A1Yissum Research Development Company of the Hebrew University of Jerusalem
- Amylin analogues4 Jun 2026US 2026/0152538 A1IP2Ipo Innovations Limited
- Peptide analogs15 May 2025US 2025/0154219 A1Adepthera LLC
- Active immunization for reducing osteoarthritic, neuropathic, and cancer pain27 Mar 2025US 2025/0099561 A1Institut Pasteur de Montevideo
- Compositions including multi-agonist peptides and methods of manufacture and use22 Feb 2024US 2024/0059753 A1
Most cited
By later US patents
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006
- Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage144US 5,013,653 ACreative BioMolecules, Inc. · 1991
- Albumin fusion proteins96US 7,592,010 B2Delta Biotechnology Limited · 2009
- Method for early detection, detection of the severity and for a treatment-accompanying assessment of the course of a sepsis76US 5,639,617 AB.R.A.H.M.S. Diagnostica GmbH · 1997
- Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections63US 6,756,483 B1B.R.A.H.M.S GmbH · 2004